Loading clinical trials...
Loading clinical trials...
SORAVE-Sorafenib and Everolimus in Solid Tumors. A Phase I Clinical Trial to Evaluate the Safety of Combined Sorafenib and Everolimus Treatment in Patients With Relapsed Solid Tumors
Conditions
Interventions
Combination of sorafenib and everolimus
Locations
1
Germany
Center for Integrated Oncology, Dep.I of Internal Medicine, University Hospital Cologne
Cologne, Germany
Start Date
July 1, 2009
Primary Completion Date
February 1, 2014
Completion Date
February 1, 2015
Last Updated
May 25, 2016
NCT07190248
NCT06305754
NCT07100080
NCT07195695
NCT06357533
NCT06731413
Lead Sponsor
University of Cologne
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions